Amanote Research
Register
Sign In
Epigenetic Activation of BRCA1 by Genistein in Vivo and Triple Negative Breast Cancer Cells Linked to Antagonism Toward Aryl Hydrocarbon Receptor
Nutrients
- Switzerland
doi 10.3390/nu11112559
Full Text
Open PDF
Abstract
Available in
full text
Categories
Nutrition
Food Science
Dietetics
Date
October 23, 2019
Authors
Unknown
Publisher
MDPI AG
Related search
Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells
PLoS ONE
Multidisciplinary
Repression of Activated Aryl Hydrocarbon Receptor–Induced Transcriptional Activation by 5α-Dihydrotestosterone in Human Prostate Cancer LNCaP and Human Breast Cancer T47D Cells
Journal of Pharmacological Sciences
Molecular Medicine
Pharmacology
Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells
British Journal of Cancer
Cancer Research
Oncology
FZD7 in Triple Negative Breast Cancer Cells
Androgen Receptor-Positive, Triple-Negative Breast Cancer
Cancer
Cancer Research
Oncology
Focal Adhesion Kinase (FAK) Activation by Estrogens Involves GPER in Triple-Negative Breast Cancer Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
BRCA1/2-negative Hereditary Triple-Negative Breast Cancers Exhibit BRCAness
International Journal of Cancer
Cancer Research
Oncology
Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
